{"id":"W2803616070","doi":"10.3390/cancers10060160","title":"A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma","year":2018,"lang":"en","type":"article","venue":"Cancers","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"National Cancer Institute; National Institute on Aging","keywords":"Gemcitabine; Medicine; Adenocarcinoma; Internal medicine; Oncology; Pancreatic ductal adenocarcinoma; Pancreatic cancer; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001698377,0.0001405089,0.0005400138,0.0001840626,0.00009169326,0.0000033361,0.00008017881,0.00004879811,0.00006910551],"category_scores_gemma":[0.0001177658,0.00009856262,0.00002359655,0.0004001294,0.0002473269,0.00008288427,0.00002275438,0.0001040836,0.000001567515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006080988,"about_ca_system_score_gemma":0.0006067898,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002808546,"about_ca_topic_score_gemma":0.0004446413,"domain_scores_codex":[0.9987957,0.00004347879,0.0002700451,0.0002856788,0.0003272823,0.0002778016],"domain_scores_gemma":[0.9988371,0.00009914423,0.000140481,0.0002884868,0.0005337815,0.0001010708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01592832,0.00334978,0.9714628,0.0001363618,0.0002206658,0.00001359949,0.00381094,0.00001043432,0.0001356021,0.00004466167,0.0001064593,0.004780365],"study_design_scores_gemma":[0.1069268,0.2001042,0.6861543,0.0003283347,0.0005061743,0.000004226582,0.003527864,0.001923938,0.0002441705,0.00004334334,0.00007491367,0.0001617348],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959942,0.00009186491,0.0002603761,0.00006570444,0.0000341041,0.0028994,0.00001406801,0.00001618014,0.0006241163],"genre_scores_gemma":[0.9977609,0.000008910146,0.001386752,0.00004764215,0.00003644142,0.0004555549,0.0000442051,0.00002332899,0.0002362639],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2853085,"threshold_uncertainty_score":0.4019267,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01995997718678652,"score_gpt":0.3362774205512779,"score_spread":0.3163174433644914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}